14.46
Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten
Institution Moves: Can Amicus Therapeutics Inc expand its profit marginsEarnings Overview Summary & Capital Efficient Trading Techniques - baoquankhu1.vn
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates - ADVFN
Amicus Therapeutics Hits New 52-Week High of $14.47 - Markets Mojo
How does Amicus Therapeutics Inc score in quality rankings2026 Biggest Moves & Community Shared Stock Ideas - baoquankhu1.vn
Patterns Watch: Will Amicus Therapeutics Inc benefit from geopolitical trendsPortfolio Gains Summary & Consistent Growth Equity Picks - baoquankhu1.vn
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
(FOLD) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Amicus Therapeutics Hits New 52-Week High of $14.48 - Markets Mojo
Panic Selling: Is Amicus Therapeutics Inc showing insider buyingWeekly Market Outlook & Daily Technical Forecast Reports - baoquankhu1.vn
Gap Down: Will Amicus Therapeutics Inc benefit from geopolitical trendsBuy Signal & Reliable Momentum Entry Alerts - baoquankhu1.vn
Will Amicus Therapeutics Inc benefit from geopolitical trends2026 Dividend Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Amicus Therapeutics stock hits 52-week high at 14.46 USD By Investing.com - Investing.com Australia
Amicus Therapeutics stock hits 52-week high at 14.46 USD - Investing.com
FOLD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Amicus Therapeutics (NASDAQ:FOLD) Hits New 1-Year HighTime to Buy? - MarketBeat
BioMarin Pharmaceutical Secures European Regulatory Approval for Amicus Therapeutics Acquisition - marketscreener.com
EU Commission OKs BioMarin's Sole Acquisition of Amicus Therapeutics - marketscreener.com
Capricorn Fund Managers Ltd Invests $3 Million in Amicus Therapeutics, Inc. $FOLD - MarketBeat
FOLD Technical Analysis & Stock Price Forecast - intellectia.ai
Amicus Therapeutics stock hits 52-week high at $14.44 By Investing.com - Investing.com South Africa
Amicus Therapeutics stock hits 52-week high at $14.44 - Investing.com
EPS Watch: Is Amicus Therapeutics Inc in a bullish channelMarket Sentiment Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
Amicus Therapeutics (NASDAQ:FOLD) Reaches New 1-Year HighStill a Buy? - MarketBeat
Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 71% One Year Total Return - Yahoo Finance
210,800 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by CIBRA Capital Ltd - MarketBeat
FOLD PE Ratio & Valuation, Is FOLD Overvalued - intellectia.ai
Recap Report: What is the long term forecast for Amicus Therapeutics Inc stockQuarterly Market Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Vanguard disaggregates holdings, reports 0% in Amicus (NASDAQ: FOLD) - Stock Titan
JPMorgan Chase & Co. Sells 94,105 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
ETFs investiert in Amicus Therapeutics, Inc.-Aktien - TradingView
Morgan Stanley Upgrades Amicus (FOLD) on IP Strength and Pipeline Expansion - MSN
Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week HighWhat's Next? - MarketBeat
Amicus Therapeutics stock hits 52-week high at 14.39 USD By Investing.com - Investing.com Canada
Amicus Therapeutics stock hits 52-week high at 14.39 USD - Investing.com
Hudson Bay Capital Management LP Cuts Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc.(NasdaqGM: FOLD) dropped from NASDAQ Biotechnology Index - marketscreener.com
FOLD Should I Buy - Intellectia AI
872,411 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Ion Asset Management Ltd. - MarketBeat
Iron Triangle Partners LP Takes Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
BioMarin to acquire rare disease drug developer Amicus for $4.8B - MSN
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And DCF Upside - Yahoo Finance
Amicus Therapeutics stock hits 52-week high at 14.38 USD By Investing.com - Investing.com Nigeria
Elevation Point Wealth Partners LLC Makes New Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Assessing Amicus Therapeutics (FOLD) Valuation After Strong Recent Share Price Momentum - simplywall.st
Amicus Therapeutics, Inc. $FOLD Shares Sold by Prosight Management LP - MarketBeat
Avoro Capital Advisors LLC Decreases Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Assessing Amicus Therapeutics (FOLD) After Strong One Year Share Price Performance - simplywall.st
Amicus Therapeutics stock hits 52-week high at 14.38 USD - Investing.com India
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):